关于MAP4K2,SPI1和CTSD在骨质疏松症中的作用的研究
Chao Sun1,2, Wanxiong He2, Leipeng Wang1,2
1The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
Cell biochemistry and biophysics
|November 25, 2024
概括
MAP4K2和CTSD影响骨髓干细胞生长和骨形成,可能影响骨质疏松症. 在这项研究中,SPI1对骨质疏松症相关特征没有影响.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 骨质疏松症 (OP) 是一种具有不平衡骨重塑的全球骨疾病.
- 生物信息学确定了MAP4K2,SPI1和CTSD作为OP中的关键基因.
- 了解这些基因在介质干细胞中的作用对于OP研究至关重要.
研究的目的:
- 研究MAP4K2,SPI1和CTSD对大鼠骨髓中酶干细胞 (BMSC) 的影响.
- 为了确定差异性基因表达是否影响骨质生成能力和相关的信号通路.
- 探索骨质疏松症的潜在治疗点.
主要方法:
- 在大鼠BMSC中为MAP4K2,SPI1和CTSD建立了差异表达系统.
- 使用的试验:CCK-8 (增殖),ALP活动/染色 (骨质分化),阿利沙林红色 (矿物化).
- 定量实时PCR (qRT-PCR) 分析了MAPK,自和亡途径中的基因表达.
主要成果:
- MAP4K2和CTSD显著影响了BMSC的扩散,骨质分化和矿化.
- MAP4K2和CTSD可以调节自和亡,有助于OP的发展.
- SPI1对OP相关的表型没有显著影响.
结论:
- 在BMSC中,MAP4K2和CTSD是骨质生成的关键调节者.
- 这些基因在自和亡途径中的作用为OP病原体提供了洞察力.
- 在本研究中研究的OP表型中,SPI1不是主要的驱动因素.
更多相关视频
09:37A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
13.1K
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
7.1K
相关概念视频
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Bone Remodeling
38.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.1K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Microtubule Associated Proteins (MAPs)
4.2K
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
4.2K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
